Notice of first launch, interruption or termination of supply of a human drug
 Date ▲HolderCodeDrugDate fromSubject
 1.7.2019CANDE s.r.o. (CRR-SK)1965BSTALEMED 50 mg/12,5 mg/200 mg (tbl flm 100x50 mg/12,5 mg/200 mg (fľ.HDPE))1.7.2019Z
 1.7.2019MERCK spol. s r.o. (MRS)91954Euthyrox 25 mikrogramov (tbl 100x25 µg (blis.PVC/Al))28.6.2019R
 1.7.2019MERCK spol. s r.o. (MRS)24824Euthyrox 25 mikrogramov (tbl 100x25 µg (blis.PP/Al))28.6.2019R
 1.7.2019sanofi-aventis groupe (SOI-1)44133TIAPRIDAL tbl (tbl 50x100 mg (blis.PVC/Al))12.6.2019O
 1.7.2019sanofi-aventis groupe (SOI-1)61178Colimycine (plv ino 50x1 MIU (liek.inj.skl.))20.5.2019R
 1.7.2019Ferring-Léčiva, a.s. (FEI-CZ)34533Minirin spray (aer nao 1x5 ml (liek.skl.s ručnou dávk.pumpičkou))26.6.2019R
 28.6.2019STALLERGENES (SLG-1)28057ALYOSTAL PRICK (sol tdp 1x3 ml (neg.kontr.) (liek.skl.))5.7.2019R
 28.6.2019STALLERGENES (SLG-1)28058ALYOSTAL PRICK (sol tdp 1x3 ml (hist.hydr.) (liek.skl.))5.7.2019R
 28.6.2019STALLERGENES (SLG-1)28059ALYOSTAL PRICK (sol tdp 1x3 ml (fosf.kod.) (liek.skl.))5.7.2019R
 28.6.2019STALLERGENES (SLG-1)53626ALYOSTAL PRICK (sol tdp 1x3 ml (100 IR/ml, 100 IC/ml, 1000 IC/ml) (liek.skl.))5.7.2019R
 28.6.2019Teva B.V. (TEV-NL-4)91376Gabapentin-Teva 300 mg (cps dur 200(2x100)x300 mg (blis.PVC/PVDC/Al))15.7.2019R
 28.6.2019ratiopharm GmbH (RAT)35321Perindopril-ratiopharm 4 mg (tbl 30x4 mg (blis.PVC/PE/PVDC/Al))15.8.2019R
 28.6.2019Teva B.V. (TEV-NL-4)62864Candibene (aer deo 1x40 ml/400 mg (fľ.skl.hnedá))26.8.2019R
 27.6.2019Astellas Pharma Europe B.V. (ASL-2)5396CXtandi 40 mg filmom obalené tablety (tbl flm 112(4x28)x40 mg (blis.PVC/PCTFE/Al))27.6.2019O
 27.6.2019Viatris Healthcare Limited (VIM-1)54475Allergodil 0,05 % očné roztokové kvapky (int opo 1x6 ml (fľ.HDPE))1.7.2019R

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To